A new trading day began on Tuesday, with Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) stock price up 3.56% from the previous day of trading, before settling in for the closing price of $63.19. RYTM’s price has ranged from $40.46 to $69.89 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -2.34% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 37.85%. With a float of $58.20 million, this company’s outstanding shares have now reached $63.49 million.
In an organization with 283 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 89.49%, operating margin of -126.13%, and the pretax margin is -123.16%.
Rhythm Pharmaceuticals Inc (RYTM) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Rhythm Pharmaceuticals Inc is 8.53%, while institutional ownership is 95.50%. The most recent insider transaction that took place on Jun 10 ’25, was worth 139,016. In this transaction Corporate Controller & CAO of this company sold 2,069 shares at a rate of $67.19, taking the stock ownership to the 1,889 shares. Before that another transaction happened on Jun 06 ’25, when Company’s Chief Human Resources Officer sold 7,031 for $68.05, making the entire transaction worth $478,435. This insider now owns 19,209 shares in total.
Rhythm Pharmaceuticals Inc (RYTM) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 37.85% per share during the next fiscal year.
Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) Trading Performance Indicators
Here are Rhythm Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.13. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 30.42.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.82, a number that is poised to hit -0.64 in the next quarter and is forecasted to reach -1.38 in one year’s time.
Technical Analysis of Rhythm Pharmaceuticals Inc (RYTM)
Let’s dig in a bit further. During the last 5-days, its volume was 0.67 million. That was better than the volume of 0.63 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 74.34%.
During the past 100 days, Rhythm Pharmaceuticals Inc’s (RYTM) raw stochastic average was set at 81.45%, which indicates a significant increase from 72.20% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 31.22% in the past 14 days, which was lower than the 51.74% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $62.55, while its 200-day Moving Average is $56.99. However, in the short run, Rhythm Pharmaceuticals Inc’s stock first resistance to watch stands at $66.82. Second resistance stands at $68.20. The third major resistance level sits at $70.20. If the price goes on to break the first support level at $63.45, it is likely to go to the next support level at $61.45. Assuming the price breaks the second support level, the third support level stands at $60.07.
Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) Key Stats
With a market capitalization of 4.16 billion, the company has a total of 63,621K Shares Outstanding. Currently, annual sales are 130,130 K while annual income is -260,600 K. The company’s previous quarter sales were 32,700 K while its latest quarter income was -49,500 K.
